检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]广东省汕头市汕头大学医学院第二附属医院皮肤科,515041
出 处:《中国临床实用医学》2010年第2期156-157,共2页China Clinical Practical Medicine
摘 要:目的观察复方甘草酸苷片联合咪唑斯汀治疗慢性荨麻疹的疗效。方法将126例慢性荨麻疹患者随机分为两组,治疗组68例口服复方甘草酸苷片75mg,3次/d,咪唑斯汀10mg,1次/d;对照组58例口服咪唑斯汀10mg,1次/d。两组疗程均为4周,评估疗效,记录不良反应。结果治疗组和对照组总有效率分别为83.83%和65.52%,差异有显著性(P〈0.05),且无明显不良反应。结论复方甘草酸苷片联合咪唑斯汀治疗慢性荨麻疹疗效好,安全可靠,值得临床推广应用。Objective To observe the clinical efficacy of Stronger Neo-Minophagen C combined with Mizollan tablets in the treatment chronic urticaria. Methods 126 chronic urticaria patients were divided randomly into two groups. The treatment group (68 cases)was treated with Stronger N eo-Minophagen C three times a day and 75 mg per time, and Mizollen tablets 10 mg one time a day; While the control group (58 eases)was treated with Mizollen tablets 10 mg one time a day. After four weeks,compare effective rate. Results The total ef- fective rate of the treatment group was 83.83% , and the control group was 65.52%, there was significant between the two groups ( P 〈 0. 05 ). And all adverse events were mild and reversible. Conclusion Stronger Neo- Minophagen C combined with Mizollen is effective and safe in treating chronic urticaria, and worth to apply to clinical use.
分 类 号:R758.24[医药卫生—皮肤病学与性病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28